← All trials
NCT04850118
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 31, 2021
- Primary completion
- Jan 31, 2024
- Completion date
- Mar 31, 2029
- First posted
- Apr 20, 2021
- Last posted
- May 21, 2021
- Enrollment
- 63
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Applied Genetic Technologies CorpLead sponsor
- Applied Genetic Technologies CorpStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.